Requirement for expert histopathological assessment of ovarian cancer and borderline tumours

The distinction between borderline ovarian tumours (BOT) and ovarian carcinoma is made by histopathological assessment. Of 64 patients managed according to institutional BOT protocols, 27 (42%) had been referred with a diagnosis of ovarian carcinoma that was subsequently changed to BOT following his...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sengupta, P S, Shanks, J H, Buckley, C H, Ryder, W D J, Davies, J, Reynolds, K, Slade, R J, Kitchener, H C, Jayson, G C
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2000
Soggetti:
Short Communication
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2374382/
https://ncbi.nlm.nih.gov/pubmed/10732741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.1999.0994
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi